TIAA FSB’s Biogen BIIB Stock Holding History

TIAA FSB’s Portfolio BIIB Stock Details BIIB Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q2	$950K	Sell	3,334 -370	-10%	-$110K	﹤0.01%	330
2023 Q1	$1.03M	Sell	3,704 -326	-8%	-$90.2K	﹤0.01%	314
2022 Q4	$1.12M	Sell	4,030 -705	-15%	-$199K	﹤0.01%	297
2022 Q3	$1.26M	Sell	4,735 -443	-9%	-$94.1K	0.01%	273
2022 Q2	$1.06M	Buy	+5,178	New	+$1.06M	﹤0.01%	319
2017 Q3	–	Sell	-13,606	Closed	-$3.69M	–	380
2017 Q2	$3.69M	Buy	+13,606	New	+$3.6M	0.03%	172

Other funds holding BIIB

Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

ClearBridge Investments New York $115B AUM 24.78% 1-Year Est. Return

TIAA FSB's BIIB Position: Q2 2023 in Review

TIAA FSB reduced its Biogen (BIIB) stake by 10% in Q2 2023, selling an estimated $110K and leaving 3,334 shares worth $950K. The position accounts for ﹤0.01% of the portfolio, ranked #330.

TIAA FSB first reported a position in BIIB in Q2 2017 and has held it in 6 quarters since. The position peaked at $3.69M in Q2 2017. 1,008 funds tracked by Wall St. Rank hold BIIB as of Q2 2023.

TIAA FSB held 3,334 shares of Biogen worth $950K as of Q2 2023.
TIAA FSB sold 370 Biogen shares in Q2 2023, an estimated $110K.
Biogen made up ﹤0.01% of TIAA FSB's portfolio in Q2 2023, its #330 holding.
TIAA FSB first reported a position in Biogen in Q2 2017 and has held it in 6 quarters since.
TIAA FSB's Biogen position peaked at $3.69M in Q2 2017.
1,008 funds tracked by Wall St. Rank held Biogen as of Q2 2023.

Based on TIAA FSB's 13F filing for Q2 2023, filed 31 Jul 2023.